Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
作者信息
Moise Leonard, Ross Ted M, Hoft Daniel F, Martin William D, De Groot Anne S
机构信息
EpiVax, Inc ., Providence, RI, USA.
Institute for Immunology and Informatics, University of Rhode Island , Providence, RI, USA.
出版信息
Expert Rev Vaccines. 2020 Sep;19(9):781-784. doi: 10.1080/14760584.2020.1825946. Epub 2020 Oct 6.
Abstract
摘要
相似文献
1
Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.利用T细胞免疫开发快速、安全且有效的新冠疫苗。
Expert Rev Vaccines. 2020 Sep;19(9):781-784. doi: 10.1080/14760584.2020.1825946. Epub 2020 Oct 6.
2
The Race to Develop a COVID-19 Vaccine.新冠疫苗研发竞赛。
Am J Nurs. 2020 Oct;120(10):14-15. doi: 10.1097/01.NAJ.0000718556.85319.00.
3
Rapid COVID-19 vaccine development.新冠疫苗的快速研发。
Science. 2020 May 29;368(6494):945-946. doi: 10.1126/science.abb8923. Epub 2020 May 8.
4
Coronavirus vaccines get a biotech boost.冠状病毒疫苗获得生物技术助力。
Nature. 2020 Jul;583(7817):647-649. doi: 10.1038/d41586-020-02154-2.
5
What the immune response to the coronavirus says about the prospects for a vaccine.对冠状病毒的免疫反应揭示了疫苗的前景。
Nature. 2020 Sep;585(7823):20-21. doi: 10.1038/d41586-020-02400-7.
6
A vaccine is not too far for COVID-19.针对新冠病毒的疫苗已为时不远。
J Infect Dev Ctries. 2020 May 31;14(5):450-453. doi: 10.3855/jidc.12744.
7
Understanding COVID-19 vaccine efficacy.了解新冠病毒疫苗的效力。
Science. 2020 Nov 13;370(6518):763-765. doi: 10.1126/science.abe5938. Epub 2020 Oct 21.
8
'I've never worked harder': the race to develop a COVID-19 vaccine.“我从未如此努力工作过”：新冠疫苗的研发竞赛
Nature. 2020 Nov;587(7833):322. doi: 10.1038/d41586-020-03139-x.
9
A timely update of global COVID-19 vaccine development.及时更新全球 COVID-19 疫苗研发进展。
Emerg Microbes Infect. 2020 Dec;9(1):2379-2380. doi: 10.1080/22221751.2020.1838246.
10
Keeping track of the SARS-CoV-2 vaccine pipeline. 跟踪 SARS-CoV-2 疫苗研发管线。
Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.
引用本文的文献
1
Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics.基于免疫信息学预测的 HLA-A*02:01 限制性 SARS-CoV-2 T 细胞表位的 DNA 疫苗的构建与功效测试。
Acta Biochim Biophys Sin (Shanghai). 2024 Apr 24;56(7):986-996. doi: 10.3724/abbs.2024039.
Zotero 插件